Evaluation of Current Surgical BPH Interventions for Young and Elderly Men
AbstractPurpose of ReviewBenign prostatic hyperplasia affects the quality of life of a significant number of men, especially as they age. There are continuous innovations in the surgical management of benign prostatic hyperplasia, but many of these innovations are studied in the core population of men 50 –70 years of age. This review focuses on the outliers of men aged 18–50 and 70 and older.Recent FindingsOlder populations have more comorbidities, higher rates of antithrombotic medications, and advanced symptoms. Properly selected older men can safely have significant objective and subjective improvement in their sym...
Source: Current Urology Reports - March 12, 2024 Category: Urology & Nephrology Source Type: research

Association between erectile dysfunction and subjective well-being in primary care patients with type 2 diabetes
ConclusionErectile dysfunction and subjective well-being were interrelated. Early detection of erectile dysfunction is essential for improving the positive mental health of men with type 2 diabetes in primary care. (Source: Diabetology International)
Source: Diabetology International - March 12, 2024 Category: Endocrinology Source Type: research

Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan's public healthcare system
CONCLUSIONS: Driven by lower retreatment and AE rates, WAVE was a cost-effective and cost-saving treatment for moderate-to-severe BPH in Japan compared to PUL, providing better outcomes at lower costs to the healthcare system.PMID:38466193 | DOI:10.1080/13696998.2024.2327920 (Source: Journal of Medical Economics)
Source: Journal of Medical Economics - March 11, 2024 Category: Health Management Authors: Hisataka Anezaki Fumiyasu Endo Georgia Swan Kenta Takashima Sirikan Rojanasarot Source Type: research

Adreno-Muscarinic Synergy of Contractile Responses From Human Hyperplastic Prostate
CONCLUSION: These experiments show that adreno-muscarinic contractile synergy is a feature of human hyperplastic prostate tissue. This has implications for the use of a combination therapy of α-blockers and anti-muscarinic agent to relieve secondary symptoms associated with benign prostatic hyperplasia, at least in men who can tolerate antimuscarinics without a risk of retention.PMID:38461856 | DOI:10.5213/inj.2346144.122 (Source: International Neurourology Journal)
Source: International Neurourology Journal - March 10, 2024 Category: Urology & Nephrology Authors: Ben T Blake-James Basu Chakrabarty Christopher H Fry Source Type: research

Adreno-Muscarinic Synergy of Contractile Responses From Human Hyperplastic Prostate
CONCLUSION: These experiments show that adreno-muscarinic contractile synergy is a feature of human hyperplastic prostate tissue. This has implications for the use of a combination therapy of α-blockers and anti-muscarinic agent to relieve secondary symptoms associated with benign prostatic hyperplasia, at least in men who can tolerate antimuscarinics without a risk of retention.PMID:38461856 | PMC:PMC10932579 | DOI:10.5213/inj.2346144.122 (Source: International Neurourology Journal)
Source: International Neurourology Journal - March 10, 2024 Category: Urology & Nephrology Authors: Ben T Blake-James Basu Chakrabarty Christopher H Fry Source Type: research